For decades, a medical puzzle has perplexed scientists: Why do cancers rarely arise in the heart? Despite its rich blood supply, both primary cardiac tumors and secondary metastases to the heart are exceedingly uncommon. Traditional explanations have focused largely on the biochemical microenvironment.
Recently, Serena Zacchigna’s team at the University of Trieste published an online paper in Science titled “Mechanical load inhibits cancer growth in mouse and human hearts.” The study proposes an entirely new physical explanation: the mechanical forces generated by the heart’s continuous, rhythmic contractions themselves constitute a powerful anti-cancer barrier.
Using an in vivo gene-editing model, the researchers directly demonstrated the heart’s innate resistance to malignant transformation. They intravenously injected an AAV9 virus expressing Cre recombinase into seven LSL-K-RasG12D/+; p53f/f genetically engineered mice, thereby simultaneously activating the oncogenic K-Ras mutation and knocking out the tumor suppressor p53. Two months later, analyses showed comparable levels of genetic recombination in the liver, skeletal muscle, and heart. Multiple rhabdomyosarcomas developed in skeletal muscles of the limbs, trunk, and neck, yet no tumors formed in the heart. This finding directly overturns the notion that “the heart is spared simply because it never encounters oncogenic signals,” and instead demonstrates that the heart harbors an active defense mechanism that suppresses cancer cell proliferation.
| Cat.No. | Product Name | Price |
|---|---|---|
| AAV00020Z | Cre Adeno-associated virus(AAV Serotype 5) | Inquiry |
| AAV00044Z | Cre Adeno-associated virus(AAV Serotype 1) | Inquiry |
| AAV00045Z | Cre Adeno-associated virus(AAV Serotype 2) | Inquiry |
| AAV00046Z | Cre Adeno-associated virus(AAV Serotype 6) | Inquiry |
| AAV00047Z | Cre Adeno-associated virus(AAV Serotype 8) | Inquiry |
| AAV00048Z | Cre Adeno-associated virus(AAV Serotype 9) | Inquiry |
| AAV00319Z | CMV-Cre AAV (Serotype Retrograde) | Inquiry |
| AAV00322Z | CAG-Cre AAV (Serotype Retrograde) | Inquiry |
| AAV00327Z | Syn-Cre AAV (Serotype Retrograde) | Inquiry |
| AAV00333Z | CAG-Cre AAV (Serotype BR1) | Inquiry |
| AAV00504Z | AAV5-hSyn-Cre | Inquiry |
| AAV00545Z | CAG-Cre AAV (Serotype AAV-BI30) | Inquiry |
| AD00299Z | Cre adenoviral particles | Inquiry |
To probe the role of mechanical forces, the team devised a clever “heterotopic heart transplantation” model: donor hearts were transplanted into the necks of recipient mice and connected to major vessels for blood supply, but because these hearts did not participate in systemic circulation, the left ventricle bore virtually no pumping load—i.e., they were “mechanically unloaded.” The results were striking: on these non-beating hearts, lung and colorectal cancer cells proliferated rapidly and formed tumors. By contrast, in normally contracting cardiac tissue, cancer cell growth was strongly inhibited. This observation was independently validated in engineered cardiac tissues where mechanical load can be precisely controlled.
From physical force to genetic switch: unveiling a complete anti-cancer signaling pathway
How are mechanical forces translated into biochemical instructions that suppress proliferation? Through spatial transcriptomics and related techniques, the study found that cancer cells within cardiac metastases exhibit a distinctive gene expression profile characterized by reduced chromatin compaction and increased openness—an epigenetic state associated with proliferation inhibition. Crucially, the researchers identified the “sensor” that links mechanical force to this state: the protein Nesprin-2. Located at the nuclear envelope, Nesprin-2 transmits mechanical stretch perceived in the cytoplasm to the nuclear interior.
Decisive evidence came from knocking down Nesprin-2 in lung cancer cells and then implanting them into normally beating mouse hearts. These cells behaved as if they could no longer “feel” mechanical force; their chromatin failed to undergo the suppressive epigenetic changes and they formed large tumors. This provides elegant proof that Nesprin-2 is the core molecular switch converting the mechanical signals of cardiac contraction into anti-cancer instructions.
Figure 1. Key mechanisms inhibiting cancer cell proliferation in the heart. (CIUCCI, Giulio, et al., 2026)
This study not only offers a concise and elegant physical solution to the century-old mystery of why the heart rarely develops cancer, but also inaugurates a new paradigm of “mechanical oncology.” It demonstrates that mechanical signaling can directly regulate cellular epigenetic states and determine cell fate. The findings open revolutionary avenues for cancer therapy: Could we design drugs that mimic mechanical signals, or apply similar mechanical stimuli to other tissues to suppress tumor growth? The power of the heartbeat not only sustains life—it may also quietly protect it.
Reference
- CIUCCI, Giulio, et al. Mechanical load inhibits cancer growth in mouse and human hearts. Science, 2026, 392.6796: eads9412.
